SLC38A5 and osteosarcoma: SLC38A5 expression was up-regulated in high-risk group than that in low-risk group, and Kaplan-Meier survival analysis in two independent cohorts revealed that higher expression of SLC38A5 predicted worse overall survival in osteosarcoma.